BFLY
Price
$8.70
Change
-$0.27 (-3.01%)
Updated
Oct 1, 12:25 PM (EDT)
Capitalization
2.44B
28 days until earnings call
Intraday BUY SELL Signals
NTRA
Price
$414.61
Change
+$1.30 (+0.31%)
Updated
Oct 1, 02:45 PM (EDT)
Capitalization
59.35B
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BFLY vs NTRA

BFLY vs NTRA Comparison Chart in %
View a ticker or compare two or three
VS
BFLY vs. NTRA commentary
Oct 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFLY is a Buy and NTRA is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BFLY vs NTRA: Fundamental Ratings
BFLY
NTRA
OUTLOOK RATING
1..100
8438
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
1008
SMR RATING
1..100
9794
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
17n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BFLY's Valuation (44) in the null industry is in the same range as NTRA (54) in the Biotechnology industry. This means that BFLY’s stock grew similarly to NTRA’s over the last 12 months.

NTRA's Profit vs Risk Rating (8) in the Biotechnology industry is significantly better than the same rating for BFLY (100) in the null industry. This means that NTRA’s stock grew significantly faster than BFLY’s over the last 12 months.

NTRA's SMR Rating (94) in the Biotechnology industry is in the same range as BFLY (97) in the null industry. This means that NTRA’s stock grew similarly to BFLY’s over the last 12 months.

NTRA's Price Growth Rating (34) in the Biotechnology industry is in the same range as BFLY (34) in the null industry. This means that NTRA’s stock grew similarly to BFLY’s over the last 12 months.

NTRA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BFLY (100) in the null industry. This means that NTRA’s stock grew similarly to BFLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BFLYNTRA
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend about 1 month ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 01, 2026
Stock price -- (BFLY: $8.96 vs. NTRA: $413.31)
Brand notoriety: BFLY and NTRA are both not notable
BFLY represents the Medical/Nursing Services, while NTRA is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BFLY: 78% vs. NTRA: 149%
Market capitalization -- BFLY: $2.44B vs. NTRA: $59.35B
BFLY [@Medical/Nursing Services] is valued at $2.44B. NTRA’s [@Medical Specialties] market capitalization is $59.35B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B. The average market capitalization across the [@Medical Specialties] industry is $20.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BFLY’s FA Score shows that 0 FA rating(s) are green while NTRA’s FA Score has 1 green FA rating(s).

  • BFLY’s FA Score: 0 green, 5 red.
  • NTRA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTRA is a better buy in the long-term than BFLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BFLY’s TA Score shows that 5 TA indicator(s) are bullish while NTRA’s TA Score has 4 bullish TA indicator(s).

  • BFLY’s TA Score: 5 bullish, 5 bearish.
  • NTRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BFLY and NTRA are a good buy in the short-term.

Price Growth

BFLY (@Medical/Nursing Services) experienced а -2.61% price change this week, while NTRA (@Medical Specialties) price change was +5.76% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.08%. For the same industry, the average monthly price growth was -5.26%, and the average quarterly price growth was -2.81%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.19%. For the same industry, the average monthly price growth was +6.22%, and the average quarterly price growth was +45.62%.

Reported Earning Dates

BFLY is expected to report earnings on Oct 29, 2026.

NTRA is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.08% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-3.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
BFLY
Daily Signal:
Gain/Loss:
NTRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QCMU22.630.05
+0.22%
Direxion Daily QCOM Bull 2X ETF (QCMU)
FDCF51.350.08
+0.15%
Fidelity Disruptive Communications ETF (FDCF)
ISSB23.350.02
+0.07%
IncomeSTKd 1x US Stocks & 1x Bitcoin Premium ETF (ISSB)
FEX132.60-0.72
-0.54%
First Trust Large Cap Core AlphaDEX Fund (FEX)
MXF20.39-0.25
-1.21%
Mexico Fund